Skip to main content

Table 1 Baseline characteristic of patients with CRC from Ruijin Hospital (N = 48)

From: Genomic signature of MTOR could be an immunogenicity marker in human colorectal cancer

Factors

Cohort (N = 48)

Gender

 Male

29 (60%)

 Female

19 (40%)

Age

  < 60 y

15 (31%)

  > 60 y

33 (69%)

MS status

 MSI-H

17 (35%)

 MSS

31 (65%)

Tumor location

 Right

17 (35%)

 Left

31 (65%)

T stage

 T2

3 (6%)

 T3

23 (48%)

 T4

22 (46%)

N stage

 N0

36 (75%)

 N1-2

12 (25%)

M stage

 M0

40 (83%)

 M1

8 (17%)

Stage

 I

3 (6%)

 II

30 (63%)

 III

8 (17%)

 IV

7 (14%)

Vascular invasion

 positive

10 (21%)

 negative

38 (79%)